Clinical Trials Directory

Trials / Completed

CompletedNCT03278743

Tea Consumption and Cognitive Performance in the Very Old

Higher Tea Consumption is Associated With Better Performance on Measures of Attention and Psychomotor Speed in the Very Old: The Newcastle 85+ Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,042 (actual)
Sponsor
Newcastle University · Academic / Other
Sex
All
Age
85 Years – 85 Years
Healthy volunteers
Accepted

Summary

Studies have found a beneficial effect of tea consumption on the reduction of risk of cognitive impairment and dementia in older aged populations. However, there is a paucity of data on these associations in the very old defined as individuals aged 85 years and over. Therefore, we hypothesized that higher tea consumption was associated with better global and domain-specific cognitive function. We investigated the relationship between tea consumption in the very old and measures of global cognitive function, memory, attention and psychomotor speed. The Newcastle 85+ Study was a longitudinal (5-years), population-based cohort study of individuals aged 85+ years in North East England, United Kingdom. The final sample included 676 community-dwelling and institutionalized men and women recruited through general medical practices. Baseline tea consumption was assessed through a 2x24-hr multiple pass recall and longitudinal measures of global and domain specific (memory, speed and attention) cognitive function through the standardized mini-mental state examination and the cognitive drug research system. Linear mixed models, controlling for demographic (e.g. age, sex and education) and health variables were used to determine whether tea consumption was protective against cognitive decline.

Conditions

Interventions

TypeNameDescription
OTHERCognitive performance and cognitive declineAssess the global and domain specific (memory, speed and attention) cognitive function at baseline and over 5 years in the high vs. low/moderate tea consumption groups

Timeline

Start date
2006-06-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2017-09-12
Last updated
2017-09-12

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03278743. Inclusion in this directory is not an endorsement.